Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcriptional profiling of sequentially generated septal neuron fates.
Turrero García M, Stegmann SK, Lacey TE, Reid CM, Hrvatin S, Weinreb C, Adam MA, Nagy MA, Harwell CC. Turrero García M, et al. Among authors: stegmann sk. Elife. 2021 Dec 1;10:e71545. doi: 10.7554/eLife.71545. Elife. 2021. PMID: 34851821 Free PMC article.
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell Therapy.
Im NG, Guillaumet-Adkins A, Wal M, Rogers AJ, Frede J, Havig CC, Yang J, Anand P, Stegmann SK, Waldschmidt JM, Sotudeh N, Niu L, Voisine J, Schweiger MR, Grassberger C, Lohr JG, Knoechel B. Im NG, et al. Among authors: stegmann sk. Cancer Immunol Res. 2022 Sep 1;10(9):1055-1068. doi: 10.1158/2326-6066.CIR-21-0626. Cancer Immunol Res. 2022. PMID: 35759797 Free PMC article.
Death Receptor 6 as a Prognostic Marker in Low-grade Glioma.
Stegmann SK, Kuhl S, Im NG, Diem-Dinh DT, Goertz L, Goldbrunner R, Timmer M. Stegmann SK, et al. Anticancer Res. 2022 Mar;42(3):1237-1245. doi: 10.21873/anticanres.15591. Anticancer Res. 2022. PMID: 35220214
Death Receptor 6 (DR6) Is Overexpressed in Astrocytomas.
Stegmann S, Werner JM, Kuhl S, Röhn G, Krischek B, Stavrinou P, Goldbrunner R, Timmer M. Stegmann S, et al. Anticancer Res. 2019 May;39(5):2299-2306. doi: 10.21873/anticanres.13346. Anticancer Res. 2019. PMID: 31092421